Short Sellers Become More Selective on Major Biotechs

Health and Healthcare

Published: July 13, 2016 8:10 am

Last Updated: January 13, 2020 5:48 am

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

The short interest data are out for the June 30 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. In fact, a cure or incredible new breakthrough in cancer or Alzheimer’s disease will be worth more than any risks from Brexit or political rhetoric from the campaign trail.

FDA rulings can make or break the biotech sector, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock then some short sellers can argue for a stock implosion down the road.

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.

Amgen Inc. (NASDAQ: AMGN) saw its short interest rise to 7.80 million shares from the previous level of 7.20 million. Shares closed most recently at $161.96, in a 52-week trading range of $130.09 to $181.81.

Biogen Inc. (NASDAQ: BIIB) had its short interest increase to 2.49 million shares from the previous 2.20 million. The stock closed Tuesday at $253.36, within a 52-week range of $223.02 to $412.24.

Celgene Corp. (NASDAQ: CELG) short interest for this settlement date decreased slightly to 8.31 million shares from the previous 8.40 million. Shares closed most recently at $103.41, in a 52-week range of $92.98 to $140.72.

Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decrease to 22.21 million shares from 24.70 million in the previous period. Shares closed Tuesday at $86.63, in a 52-week trading range of $77.92 to $120.37.

MannKind Corp. (NASDAQ: MNKD) saw its short interest increase to 85.96 million shares. The previous reading was 81.40 million. Shares closed most recently at $1.13, in a 52-week trading range of $0.64 to $5.80.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest decreased ever so slightly to 4.74 million, compared to the previous level of 4.75 million. Shares closed most recently at $125.35, in a 52-week range of $110.56 to $208.88.

The Average American Is Losing Their Savings Every Day (Sponsor)

If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4% today, and inflation is much higher. Checking accounts are even worse.

Every day you don’t move to a high-yield savings account that beats inflation, you lose more and more value.

But there is good news. To win qualified customers, some accounts are paying 9-10x this national average. That’s an incredible way to keep your money safe, and get paid at the same time. Our top pick for high yield savings accounts includes other one time cash bonuses, and is FDIC insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes and your money could be working for you.